Excipial U Lipolotio

Excipial is a well-known dermatological brand specializing in high-quality skin care solutions, particularly the U Lipolotio range which contains urea to support the skin's natural barrier. Originally developed by the Swiss pharmaceutical company Spirig Pharma AG, the brand has a long-standing reputation for medical-grade skin care prescribed by dermatologists across Europe.

In 2013, Spirig Pharma was acquired by Galderma, a global leader in medical dermatology. Today, Excipial is a core part of Galderma's consumer skin health portfolio. While the brand has its roots and significant manufacturing ties to Egerkingen, Switzerland, its products are distributed and occasionally manufactured in various facilities across Europe to meet global demand. Galderma itself, once a joint venture between Nestlé and L'Oréal, is now an independent global company headquartered in Switzerland.